Lindbrook Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $63.8K | Sell |
4,292
-859
| -17% | -$12.8K | 0.01% | 890 |
|
|
2024
Q4 | $68.2K | Buy |
5,151
+2,029
| +65% | +$26.9K | 0.01% | 686 |
|
|
2024
Q3 | $44.4K | Buy |
3,122
+527
| +20% | +$7.49K | ﹤0.01% | 878 |
|
|
2024
Q2 | $33.6K | Sell |
2,595
-1,800
| -41% | -$23.3K | ﹤0.01% | 970 |
|
|
2024
Q1 | $61K | Buy |
4,395
+330
| +8% | +$4.58K | 0.01% | 704 |
|
|
2023
Q4 | $58K | Buy |
4,065
+1,174
| +41% | +$16.8K | 0.01% | 704 |
|
|
2023
Q3 | $44.7K | Sell |
2,891
-2,852
| -50% | -$44.1K | 0.01% | 733 |
|
|
2023
Q2 | $90.2K | Sell |
5,743
-1,737
| -23% | -$27.3K | 0.01% | 515 |
|
|
2023
Q1 | $123K | Buy |
7,480
+2,935
| +65% | +$48.4K | 0.01% | 427 |
|
|
2022
Q4 | $70.9K | Sell |
4,545
-2,107
| -32% | -$32.9K | 0.01% | 575 |
|
|
2022
Q3 | $86K | Buy |
6,652
+628
| +10% | +$8.12K | 0.01% | 478 |
|
|
2022
Q2 | $85K | Sell |
6,024
-1,219
| -17% | -$17.2K | 0.01% | 486 |
|
|
2022
Q1 | $104K | Buy |
7,243
+1,978
| +38% | +$28.4K | 0.02% | 451 |
|
|
2021
Q4 | $72K | Sell |
5,265
-381
| -7% | -$5.21K | 0.01% | 600 |
|
|
2021
Q3 | $92K | Buy |
5,646
+306
| +6% | +$4.99K | 0.02% | 281 |
|
|
2021
Q2 | $90K | Sell |
5,340
-1,676
| -24% | -$28.2K | 0.02% | 311 |
|
|
2021
Q1 | $128K | Buy |
7,016
+586
| +9% | +$10.7K | 0.03% | 228 |
|
|
2020
Q4 | $117K | Buy |
6,430
+582
| +10% | +$10.6K | 0.03% | 214 |
|
|
2020
Q3 | $104K | Buy |
5,848
+250
| +4% | +$4.45K | 0.03% | 199 |
|
|
2020
Q2 | $100K | Buy |
5,598
+1,333
| +31% | +$23.8K | 0.03% | 205 |
|
|
2020
Q1 | $65K | Sell |
4,265
-765
| -15% | -$11.7K | 0.02% | 261 |
|
|
2019
Q4 | $99K | Sell |
5,030
-777
| -13% | -$15.3K | 0.03% | 245 |
|
|
2019
Q3 | $100K | Buy |
5,807
+2,376
| +69% | +$40.9K | 0.04% | 239 |
|
|
2019
Q2 | $60K | Sell |
3,431
-4,200
| -55% | -$73.4K | 0.02% | 357 |
|
|
2019
Q1 | $155K | Buy |
+7,631
| New | +$155K | 0.06% | 164 |
|